{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:14:39Z","timestamp":1773155679567,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinimag.2025.110545","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:14:48Z","timestamp":1749557688000},"page":"110545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Is 18F-FDG-PET\/CT useful in staging of locally advanced signet-ring cell esophageal adenocarcinoma?"],"prefix":"10.1016","volume":"125","author":[{"given":"Sonia L.","family":"Betancourt Cuellar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo F.","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Atiyah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne L.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy J.","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"Clin J Gastroenterol"},{"issue":"17","key":"10.1016\/j.clinimag.2025.110545_bb0020","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/cncr.28099","article-title":"Prognostic implications of signet ring cell histology in esophageal adenocarcinoma","volume":"119","author":"Yendamuri","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110545_bb0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jtcvs.2020.08.108","article-title":"Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy","volume":"162","author":"Corsini","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/SLA.0000000000000689","article-title":"Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior","volume":"260","author":"Nafteux","year":"2014","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0035","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.athoracsur.2013.06.047","article-title":"Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis","volume":"96","author":"Enlow","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0040","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.athoracsur.2014.04.099","article-title":"Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation","volume":"98","author":"Patel","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"40","key":"10.1016\/j.clinimag.2025.110545_bb0045","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","article-title":"Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge","volume":"21","author":"Pernot","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.athoracsur.2020.04.134","article-title":"Signet ring cell histology confers worse overall survival in treated esophageal adenocarcinoma","volume":"111","author":"Tang","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"10184","key":"10.1016\/j.clinimag.2025.110545_bb0055","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clinimag.2025.110545_bb0060","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.21037\/tcr-22-1238","article-title":"Clinical features and prognostic factors of esophageal signet ring cell carcinoma: construction and validation of a model based on the SEER database","volume":"11","author":"Xie","year":"2022","journal-title":"Transl Cancer Res"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/annonc\/mdw560","article-title":"Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study","volume":"28","author":"Markar","year":"2017","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110545_bb0070","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/JTO.0000000000000006","article-title":"Clinical utility of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the staging of patients with potentially resectable esophageal cancer","volume":"8","author":"You","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0075","first-page":"113","article-title":"The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review","volume":"34","author":"Zemanova","year":"2021","journal-title":"Klin Onkol"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.rcl.2020.11.008","article-title":"Esophageal cancer: tumor-node-metastasis staging","volume":"59","author":"Betancourt-Cuellar","year":"2021","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110545_bb0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00259-018-4118-9","article-title":"Propensity score analysis of 18-FDG PET\/CT-enhanced staging in patients undergoing surgery for esophageal cancer","volume":"46","author":"Patel","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110545_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/ijnm.ijnm_118_23","article-title":"Utility of [18F]FDG- PET\/CT in initial staging and management of patients with esophageal carcinoma: a tertiary care center experience","volume":"39","author":"Kommi","year":"2024","journal-title":"Indian J Nucl Med"},{"issue":"11","key":"10.1016\/j.clinimag.2025.110545_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112668","article-title":"PET-CT in clinical adult oncology: III. Gastrointestinal malignancies","volume":"14","author":"Koppula","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0100","first-page":"144","article-title":"Role of 18F-FDG PET\/CT in comparison with CECT for whole-body assessment of patients with esophageal cancer","volume":"110","author":"Altini","year":"2019","journal-title":"Recenti Prog Med"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox113","article-title":"Accuracy of preoperative staging for a priori resectable esophageal cancer","volume":"31","author":"Winiker","year":"2018","journal-title":"Dis Esophagus"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0110","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00464-009-0783-x","article-title":"Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer","volume":"24","author":"Choi","year":"2010","journal-title":"Surg Endosc"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110545_bb0115","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/MNM.0000000000001481","article-title":"18F-FDG PET and PET\/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review","volume":"42","author":"Dondi","year":"2021","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00330-022-09084-9","article-title":"Comparison of [(68)Ga]Ga-FAPI and [(18)F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s13139-010-0058-4","article-title":"Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma","volume":"45","author":"Choi","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4174\/jkss.2011.81.2.104","article-title":"F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer","volume":"81","author":"Ha","year":"2011","journal-title":"J Korean Surg Soc"},{"key":"10.1016\/j.clinimag.2025.110545_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijscr.2017.05.026","article-title":"Limitations in the use of 18F-FDG PET in the pre-operative staging of gastric cancer: a case series","volume":"36","author":"Fonocho","year":"2017","journal-title":"Int J Surg Case Rep"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5230\/jgc.2012.12.3.179","article-title":"18F-2-Deoxy-2-Fluoro-D-glucose positron emission tomography: computed tomography for preoperative staging in gastric cancer patients","volume":"12","author":"Youn","year":"2012","journal-title":"J Gastric Cancer"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000436972","article-title":"Initial standardized uptake value of positron emission tomography influences the prognosis of patients with localized gastric adenocarcinoma treated preoperatively","volume":"89","author":"Charalampakis","year":"2015","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","article-title":"FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings","volume":"30","author":"Stahl","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/030089161410000214","article-title":"Usefulness of combined PET\/CT to assess regional lymph node involvement in gastric cancer","volume":"100","author":"Park","year":"2014","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0002-9610(02)00932-7","article-title":"Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer","volume":"184","author":"Kato","year":"2002","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-003-7191-5","article-title":"Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer","volume":"28","author":"Mochiki","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.clinimag.2025.110545_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7819-8-86","article-title":"The efficacy of preoperative PET\/CT for prediction of curability in surgery for locally advanced gastric carcinoma","volume":"8","author":"Hur","year":"2010","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4274\/mirt.galenos.2020.75537","article-title":"Metabolic characteristics and diagnostic contribution of (18)F-FDG PET\/CT in gastric carcinomas","volume":"29","author":"Arslan","year":"2020","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110545_bb0180","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.crad.2008.05.010","article-title":"The role of 18F-FDG PET\/CT in the evaluation of oesophageal carcinoma","volume":"63","author":"Chowdhury","year":"2008","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00259-005-1887-8","article-title":"Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer","volume":"33","author":"Kim","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110545_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cpet.2017.05.001","article-title":"PET\/computed tomography scanning and precision medicine: esophageal cancer","volume":"12","author":"Goel","year":"2017","journal-title":"PET Clin."},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","article-title":"Staging investigations for oesophageal cancer: a meta-analysis","volume":"98","author":"van Vliet","year":"2008","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.suronc.2013.02.003","article-title":"Meta-analysis of 18FDG PET-CT for nodal staging in patients with esophageal cancer","volume":"22","author":"Shi","year":"2013","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110545_bb0205","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1556-0864(15)31614-2","article-title":"Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging","volume":"1","author":"Erasmus","year":"2006","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.clinimag.2025.110545_bb0210","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.20585","article-title":"2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma","volume":"101","author":"Swisher","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110545_bb0215","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clinimag.2025.110545_bb0220","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.rlu.0000090936.30974.e2","article-title":"Radiation-induced esophagitis on FDG PET imaging","volume":"28","author":"Bhargava","year":"2003","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110545_bb0225","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/SLA.0000000000001902","article-title":"Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer?","volume":"264","author":"Heneghan","year":"2016","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110545_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/SLA.0000000000003397","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"271","author":"Eyck","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinimag.2025.110545_bb0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/00365520600664409","article-title":"Role of positron emission tomography in the (re-)staging of oesophageal cancer","volume":"243","author":"Westerterp","year":"2006","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110545_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12885-020-6669-y","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110545_bb0245","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jso.27774","article-title":"Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma","volume":"130","author":"Mitchell","year":"2024","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110545_bb0250","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/1078-0432.CCR-04-1840","article-title":"Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma","volume":"11","author":"Chirieac","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125001457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125001457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:21:17Z","timestamp":1755501677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707125001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S0899707125001457"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110545","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is 18F-FDG-PET\/CT useful in staging of locally advanced signet-ring cell esophageal adenocarcinoma?","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110545"}}